Moreover, as CAFs reportedly can compete metabolically with T cells, FAP-CAR T cells also likely alter the metabolic status of the TME in favor of endogenous anti-tumor immunity and functionality of adaptively transferred CAR T cells39. This evidence concerns the gene FAP and neoplasm.